Skip to main content

Table 1 Basic characteristics of infant patients

From: Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants

  Vancomycin-lock group (n = 68) Control group (n = 69) p value
Gender (male, n (%)) 42 (61.8) 34 (49.3) 0.170*
Gestational age, Wk 29.8 ± 1.90 30.1 ± 2.33 0.323
Birth weight, Kg 1.2 ± 0.19 1.3 ± 0.23 0.765
5-min APGAR score 8.29 ± 1.04 8.7 ± 0.71 0.010
Comorbilities
 Neonatal sepsis, n (%) 43 (63.2) 42 (60.9) 0.861*
 NRDS, n (%) 46 (67.6) 44 (63.8) 0.720*
 PDA, n (%) 30 (44.1) 31 (44.9) 1.000*
 IVH, n (%) 11 (16.2) 16 (23.2) 0.391*
 NEC, n (%) 6 (8.8) 7 (10.1) 1.000*
 Meningitis, n (%) 4 (5.9) 15 (21.7) 0.012*
PROM time, h 40.2 ± 114 45.3 ± 92.9 0.776
MV time, d 12.8 ± 13.1 17.0 ± 17.9 0.115
PICC time, d 33.0 ± 12.7 33.7 ± 19.6 0.798
TPN or PPN time, d 35.2 ± 15.7 33.9 ± 17.8 0.660
Hospital stay, d 48.3 ± 16.6 51.8 ± 28.2 0.376
Hospitalization costs, RMB (Yuan) 110,000 ± 53,000 118,000 ± 80,000 0.491
  1. Note: *showed chi-square test, and other analysis was t-test; NRDS neonatal respiratory distress syndrome, PDA patent ductus arteriosus, IVH intraventricular hemorrhage, NEC necrotizing enterocolitis, PROM premature rupture of membrane, MV mechanical ventilation, PICC peripherally inserted central catheters, TPN total parenteral nutrition, PPN part parenteral nutrition